HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Co-treatment With Golimumab and Vedolizumab to Treat Severe UC and Associated Spondyloarthropathy.

AuthorsXavier Roblin, Stéphane Paul, Shomron Ben-Horin
JournalJournal of Crohn's & colitis (J Crohns Colitis) Vol. 12 Issue 3 Pg. 379-380 (Feb 28 2018) ISSN: 1876-4479 [Electronic] England
PMID29088342 (Publication Type: Case Reports, Letter)
Chemical References
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antirheumatic Agents
  • Gastrointestinal Agents
  • golimumab
  • vedolizumab
Topics
  • Antibodies, Monoclonal (therapeutic use)
  • Antibodies, Monoclonal, Humanized (therapeutic use)
  • Antirheumatic Agents (therapeutic use)
  • Colitis, Ulcerative (complications, drug therapy)
  • Drug Therapy, Combination
  • Female
  • Gastrointestinal Agents (therapeutic use)
  • Humans
  • Middle Aged
  • Spondylitis, Ankylosing (complications, drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: